Bitcoin, Ethereum, and XRP all plunged sharply — yet in the middle of the panic, one project unexpectedly surged with […] The post Crypto Market Crash Today: Why BTC, ETH, and XRP Are Falling – But This Top Crypto Presale Is Attracting Whales appeared first on Coindoo.Bitcoin, Ethereum, and XRP all plunged sharply — yet in the middle of the panic, one project unexpectedly surged with […] The post Crypto Market Crash Today: Why BTC, ETH, and XRP Are Falling – But This Top Crypto Presale Is Attracting Whales appeared first on Coindoo.

Crypto Market Crash Today: Why BTC, ETH, and XRP Are Falling – But This Top Crypto Presale Is Attracting Whales

2025/12/02 18:28
6 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Bitcoin, Ethereum, and XRP all plunged sharply — yet in the middle of the panic, one project unexpectedly surged with fresh whale inflows. In fact, analysts now say this might be the Top Crypto Presale to Buy, especially while major assets remain under pressure.

Bitcoin sank nearly 5%, sliding toward $86,600 as volatility increased. Ethereum fell 5.5%, with prices threatening to break below the critical $2,800 support zone. XRP also dropped over 4%, moving dangerously close to $1.90. But while the rest of the market was drowning in red, large investors began quietly accumulating a new presale project; BlockchainFX, that remained unaffected by the crash — strengthening its position as the Top Crypto Presale to Buy during a turbulent start to December.

Macro Forces Trigger a Market-Wide Sell-Off

The downturn was fueled by a storm of macroeconomic uncertainty. With the Federal Reserve set to make a major interest rate decision on December 9–10, investors have shifted into risk-off mode. Although markets expect a rate cut, mixed economic indicators and sharp volatility in equities have created fear across all sectors.

This panic quickly spread to crypto. As prices fell, nearly $637 million in leveraged positions were forcibly liquidated, triggering cascading sell-offs and rapid algorithmic trading pressure. Thin weekend liquidity deepened the impact, accelerating declines for BTC, ETH, and XRP.

Even tech stocks—including Nvidia and Microsoft—suffered heavy selling, sending nervous investors into traditional safe-haven assets like gold. With weak Bitcoin ETF inflows and a lack of aggressive dip buyers, December is shaping up to be a volatile and unpredictable month.

But for those who understand market cycles, these crashes often reveal one type of asset that thrives during chaos: presales. And right now, one project is emerging as the top-choice hedge against short-term volatility, widely called the Top Crypto Presale to Buy today.

Whales Are Flocking to This Presale — Here’s Why It’s Booming During a Crash

While BTC, ETH, and XRP were falling, whale wallets began pouring money into one standout presale, proving that early-stage tokens with fixed prices are becoming the preferred strategy during market turbulence. These investors are using the downturn to enter BlockchainFX that does not fluctuate with daily market swings, making it the Top Crypto Presale to Buy for anyone seeking stable entry points with massive upside potential.

Here’s what’s driving the whale surge:

1. Presale Prices Don’t Move With Market Volatility

A token priced at $0.03stays at $0.03, even during a market crash. That stability alone is drawing large-scale buyers desperate to avoid the constant whiplash of liquidations and sudden dips.

2. Huge Bonus Code: CYBER50 — Get 50% More BFX Tokens

As shown in the Cyber Monday promotional banner, BlockchainFX is offering an exclusive 50% bonus for early buyers using:

🎉 BONUS CODE: CYBER50 Get 50% MORE $BFX tokens instantly

This code has become a major catalyst for whale inflows. Instead of buying BTC or ETH while prices slide lower, whales are loading up on discounted BFX + a massive 50% bonus, essentially multiplying their allocation during one of the best accumulation windows of the year.

This alone has turned the token into one of the most talked-about opportunities — repeatedly labeled as the Top Crypto Presale to Buy on social platforms, Telegram groups, and analyst reports.

3. Legendary Upside Potential

With the presale still unaffected by the broader crash and investors rushing to capitalize on bonuses while the price is frozen at early stages, analysts have repeatedly highlighted this project as the Top Crypto Presale to Buy for anyone seeking both protection from volatility and long-term growth.

ETF Weakness, AI Stock Sell-Off, and Liquidity Crunch Intensify Fear

The severity of the crash is also tied to weakening Bitcoin ETF inflows, a sharp rotation out of AI mega-caps, and the broader adoption of gold and conservative assets. With Nvidia, AMD, Microsoft, and other AI players facing increased selling pressure, investor appetite for risk is shrinking fast.

As a result, many traders have temporarily abandoned spot assets and instead shifted toward safer early-stage entries—keyword being “safer”—where they can lock in tokens at guaranteed prices. This is exactly why the rising presale continues being recognized as the Top Crypto Presale to Buy across several top analyst channels.

Forced Liquidations Deepen the Crash

The collapse of over $637 million in long positions rippled across the entire market. Bitcoin’s slide toward $86,600 triggered additional liquidations, while Ethereum’s push toward $2,800 forced traders to unwind more exposure. XRP’s 4% drop further added to overall market panic.

Yet while top assets struggled under relentless liquidation pressure, early-stage presale buyers remained unaffected — strengthening the narrative that the Top Crypto Presale to Buy right now is the one untouched by liquidation engines, ETF outflows, or macro shocks.

December Outlook: More Volatility Ahead?

Analysts warn that without strong ETF inflows or macro stability, crypto may face continuous turbulence through mid-December. If BTC loses key support levels or ETH breaks down further, the correction could worsen.

This environment is pushing even more capital toward projects offering:

  • Stable entry points
  • Massive bonuses
  • High upside potential
  • Immunity from short-term volatility

Combine these factors, and the result is clear: this rising project remains the Top Crypto Presale to Buy even as the market shakes violently.

Final Thoughts — Market Crash Creates the Perfect Storm for Presale Demand

The December 1 crash proves one universal truth: capital doesn’t disappear — it moves. And right now, it’s flowing directly into the Top Crypto Presale to Buy as whales look for stability and early-stage exponential potential.

With Bitcoin, Ethereum, and XRP all falling sharply, smart investors are shifting into a presale that:

  • Has fixed pricing
  • Offers huge upside
  • Includes a 50% Cyber Monday bonus (CYBER50)
  • Remains immune to market volatility

It’s no surprise analysts and whale wallets alike are calling this the Top Crypto Presale to Buy during a shaky market.

Find Out More Information Here:

Website: https://blockchainfx.com/ 

X: https://x.com/BlockchainFX.com 

Telegram Chat: https://t.me/blockchainfx_chat


This publication is sponsored and written by a third party. Coindoo does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or any other materials on this page. Readers are encouraged to conduct their own research before engaging in any cryptocurrency-related actions. Coindoo will not be liable, directly or indirectly, for any damages or losses resulting from the use of or reliance on any content, goods, or services mentioned. Always do your own researchs.

The post Crypto Market Crash Today: Why BTC, ETH, and XRP Are Falling – But This Top Crypto Presale Is Attracting Whales appeared first on Coindoo.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$71,424.5
$71,424.5$71,424.5
+2.21%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups

Why YouCam AI API is the Secret Weapon for E-Commerce Startups

 The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Share
Techbullion2026/03/25 14:34
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26